Terms: = Sarcomas AND ER, estrogen receptor AND Treatment
214 results:
1. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC; Chang TC; Wang Y; Guo L; Gao Y; Bikorimana E; Lemoff A; Fang YV; Zhang H; Zhang Y; Ye D; Soria-Bretones I; Servetto A; Lee KM; Luo X; Otto JJ; Akamatsu H; Napolitano F; Mani R; Cescon DW; Xu L; Xie Y; Mendell JT; Hanker AB; Arteaga CL
Nat Commun; 2024 Mar; 15(1):2287. PubMed ID: 38480701
[TBL] [Abstract] [Full Text] [Related]
2. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract] [Full Text] [Related]
3. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
5. Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients.
Saxena R; Chakrapani B; Sarath Krishnan MP; Gupta A; Gupta S; Das J; Gupta SC; Mirza AA; Rao S; Goyal B
Sci Rep; 2023 Nov; 13(1):19101. PubMed ID: 37925508
[TBL] [Abstract] [Full Text] [Related]
6. Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients.
Ramon-Luing LA; Flores-Gonzalez J; Angel García-Rojas L; Islas-Muñoz B; Volkow-Fernández P; Chavez-Galan L
Clin Exp Immunol; 2024 Feb; 215(2):190-201. PubMed ID: 37904542
[TBL] [Abstract] [Full Text] [Related]
7. Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma.
Cimmino A; Fasciglione GF; Gioia M; Marini S; Ciaccio C
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686148
[TBL] [Abstract] [Full Text] [Related]
8. The Application of 18 F-FES PET in Clinical Cancer Care : A Systematic Review.
Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
[TBL] [Abstract] [Full Text] [Related]
9. Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology.
Tian M; Yang A; Lu Q; Zhang X; Liu G; Liu G
Medicine (Baltimore); 2023 May; 102(20):e33189. PubMed ID: 37335709
[TBL] [Abstract] [Full Text] [Related]
10. [Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group].
Karabajakian A; Genestie C; Meeus P; Guyon F; Llacer Moscardo C; Croce S; Taieb S; Duffaud F; Pautier P; Ray-Coquard I; Blay JY
Bull Cancer; 2023; 110(7-8):836-843. PubMed ID: 37202293
[TBL] [Abstract] [Full Text] [Related]
11. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
[TBL] [Abstract] [Full Text] [Related]
12. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
13. Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin.
Wei H; Du X; Zhao H; Sun P; Yang J
Int J Clin Pract; 2023; 2023():3093945. PubMed ID: 36756222
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
[TBL] [Abstract] [Full Text] [Related]
15. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
16. Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition.
Li X; Wang F; Zhang X; Sun Q; Kuang E
PLoS Pathog; 2023 Jan; 19(1):e1011103. PubMed ID: 36656913
[TBL] [Abstract] [Full Text] [Related]
17. Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma.
Zhu P; Li T; Li Q; Gu Y; Shu Y; Hu K; Chen L; Peng X; Peng J; Hao L
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551309
[TBL] [Abstract] [Full Text] [Related]
18. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating KLF4 stability.
Wang Y; Zheng S; Han J; Li N; Ji R; Li X; Han C; Zhao W; Zhang L
J Exp Clin Cancer Res; 2022 Dec; 41(1):354. PubMed ID: 36539799
[TBL] [Abstract] [Full Text] [Related]
19. Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma.
Hinchcliff E; Rumpf J; Ratan R; Fleming ND; Jazaeri A; Fellman B; Meyer L; Soliman P
Gynecol Oncol; 2022 Dec; 167(3):490-495. PubMed ID: 36270831
[TBL] [Abstract] [Full Text] [Related]
20. Pazopanib restricts small cell lung cancer proliferation via reactive oxygen species-mediated endoplasmic reticulum stress.
Li Y; Chen C; Liu HL; Li CG; Zhang ZF; Wang CL
Thorac Cancer; 2022 Sep; 13(17):2421-2428. PubMed ID: 35866204
[TBL] [Abstract] [Full Text] [Related]
[Next]
